"Chemokines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; (CHEMOKINES, C); CC; (CHEMOKINES, CC); and CXC; (CHEMOKINES, CXC); according to variations in a shared cysteine motif.
| Descriptor ID |
D018925
|
| MeSH Number(s) |
D12.644.276.374.200 D12.776.467.374.200 D23.125.300 D23.469.200 D23.529.374.200
|
| Concept/Terms |
Chemokines- Chemokines
- Cytokines, Chemotactic
- Intercrines
- Chemotactic Cytokines
|
Below are MeSH descriptors whose meaning is more general than "Chemokines".
Below are MeSH descriptors whose meaning is more specific than "Chemokines".
This graph shows the total number of publications written about "Chemokines" by people in this website by year, and whether "Chemokines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1997 | 2 | 0 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 3 | 2 | 5 |
| 2002 | 4 | 3 | 7 |
| 2003 | 4 | 3 | 7 |
| 2004 | 2 | 2 | 4 |
| 2005 | 5 | 6 | 11 |
| 2006 | 5 | 7 | 12 |
| 2007 | 5 | 4 | 9 |
| 2008 | 2 | 14 | 16 |
| 2009 | 3 | 7 | 10 |
| 2010 | 6 | 9 | 15 |
| 2011 | 4 | 14 | 18 |
| 2012 | 4 | 5 | 9 |
| 2013 | 2 | 8 | 10 |
| 2014 | 2 | 7 | 9 |
| 2015 | 1 | 4 | 5 |
| 2016 | 2 | 2 | 4 |
| 2017 | 2 | 3 | 5 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 7 | 8 |
| 2020 | 1 | 2 | 3 |
| 2021 | 0 | 3 | 3 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokines" by people in Profiles.
-
Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models. Clin Cancer Res. 2024 Oct 01; 30(19):4434-4449.
-
Tumor-Targeted Nonablative Radiation Promotes Solid Tumor CAR T-cell Therapy Efficacy. Cancer Immunol Res. 2023 10 04; 11(10):1314-1331.
-
Characterization of Chemotaxis-Associated Gene Dysregulation in Myeloid Cell Populations in the Lungs during Lipopolysaccharide-Mediated Acute Lung Injury. J Immunol. 2023 06 15; 210(12):2016-2028.
-
Interleukins, Chemokines, and Tumor Necrosis Factor Superfamily Ligands in the Pathogenesis of West Nile Virus Infection. Viruses. 2023 03 22; 15(3).
-
Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients. J Neurol Sci. 2021 Nov 15; 430:120023.
-
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell. 2021 04 29; 184(9):2316-2331.e15.
-
Disruption of DNA polymerase ? engages an innate immune response. Cell Rep. 2021 02 23; 34(8):108775.
-
Targeted urine proteomics in lupus nephritis - a meta-analysis. Expert Rev Proteomics. 2020 10; 17(10):767-776.
-
Bovine Ovarian Cortex Tissue Culture. J Vis Exp. 2021 01 14; (167).
-
Uncovering the secreted signals and transcription factors regulating the development of mammalian middle ear ossicles. Dev Dyn. 2020 12; 249(12):1410-1424.